Insiders Updates
Insider Selling: Podlesak Dennis, Syndax Pharmaceuticals Inc [SNDX] Director divested 19,200 shares
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Menu
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
In a filing, Syndax Pharmaceuticals Inc revealed its Chief Financial Officer Goldan Keith A. unloaded Company’s shares for reported $12033.0
In a filing, Syndax Pharmaceuticals Inc revealed its Chief Financial Officer Goldan Keith A. unloaded Company’s shares for reported $12033.0
Syndax Pharmaceuticals Inc’s recently made public that its Chief Financial Officer Goldan Keith A. unloaded Company’s shares for reported $12033.0
Syndax Pharmaceuticals, Inc. (SNDX), a clinical-stage healthcare company that focuses on an HDAC inhibitor for tumors and specializes in cancer